Batch tested by Janoshik Analytical. Verify any report with its key on Janoshik's site. See the certificates →

Order before 11am Central for same-day dispatch

Ipamorelin · 11 cited studies214 nmStandard UV detection wavelength for peptide characterization via HPLC

What Is HPLC Testing?

Published · Ouralus research desk

High-performance liquid chromatography (HPLC) separates 5-10 distinct molecular components in a peptide sample by their retention time on a packed column, with a pressurized pump driving the sample through the stationary phase while a UV detector measures light absorption at 214 nm to quantify each peak. Area-percent purity—calculated by dividing the target peak area by total peak area—reports the fractional composition of the sample, typically ranging from 85–99% for research peptides.

HPLC Instrumentation and Separation Principle

An HPLC system comprises a sample introduction port, a high-pressure pump, a chromatographic column, and a detector. The pump drives a mobile phase (typically 0.1% aqueous formic acid transitioning to organic solvent) through a steel column packed with 3–5 micrometer silica particles, whose surface is coated with a nonpolar alkyl chain (C18, C8, or C4). Peptides and their impurities partition between the mobile phase and this stationary phase on the basis of hydrophobicity; compounds with greater nonpolar surface area bind longer and elute later. Separation is complete when all components exit as distinct peaks within the run window. The column temperature is typically maintained at 25–40°C to ensure reproducible retention times and minimize peak tailing caused by secondary interactions with exposed silanol groups on the column support.In vitro · PMID 33443297Review · PMID 35460196

The detector measures UV absorption at a wavelength where the target compound absorbs strongly. For peptides, 214 nm is standard because the peptide bond (the amide linkage connecting amino acids) has a strong absorption maximum at this wavelength, making the method sensitive and universal across all sequences. The detector generates a chromatogram—a plot of signal intensity versus time—in which each peak represents a distinct molecular species. Peak area, integrated automatically by software, is proportional to the concentration of each species. Modern HPLC detectors have signal-to-noise ratios exceeding 1000:1, enabling detection of impurities present at levels as low as 0.1–0.5% relative to the main component, depending on retention time separation and baseline stability.Review · PMID 27645457Review · PMID 36526726

Reverse-Phase HPLC Method Development

Reverse-phase HPLC (RP-HPLC) begins with a mobile phase rich in aqueous solvent and gradually increases the proportion of organic solvent (acetonitrile or methanol) over the course of the run. This gradient is tailored for each peptide to optimize separation between the target compound and synthesis byproducts. The rate of increase (the gradient slope), the initial and final organic concentrations, and the overall run duration are adjusted to achieve sufficient resolution—the ability to separate peaks that differ in retention time by as little as 0.1 minutes. Common gradient programs range from 5% to 95% organic solvent over 10–30 minutes, with flow rates between 0.5 and 1.0 milliliters per minute. Steeper gradients (reaching the organic phase more quickly) shorten run times but may sacrifice resolution; gentler gradients optimize separation at the cost of longer analysis times.In vitro · PMID 35988299Review · PMID 20369231

Method development requires testing multiple columns, gradient programs, and mobile-phase compositions to find conditions that separate the target peptide from related compounds such as truncated variants, out-of-frame products from synthesis, and oxidized forms. Literature reports show that optimization typically involves 10–30 experimental runs. Once optimized, the method is reproducible: repeated runs on the same sample yield retention times within ±2% and peak areas within ±5% of the mean.In vitro · PMID 33443297In vitro · PMID 24966037

Purity Calculation and Area-Percent Quantification

HPLC purity is reported as area percent: the sum of the target peptide peak area divided by the sum of all detected peak areas, multiplied by 100. Integration software identifies peak boundaries automatically by finding local minima in the baseline. A sample showing a single large peak at 95% purity indicates that the target compound comprises 95% of the total peak area; the remaining 5% represents impurities and degradation products. Area-percent purity assumes that all compounds detected have similar extinction coefficients at the detection wavelength—a reasonable approximation for peptides, where all contain peptide bonds absorbing at 214 nm.In vitro · PMID 29978532In vitro · PMID 33443297

The detection limit—the smallest quantity of peptide the method can reliably quantify—depends on the signal-to-noise ratio of the instrument and the extinction coefficient of the peptide. Most RP-HPLC methods detect impurities at concentrations of 0.5–2% relative to the target compound. Reporting the method's detection and quantification limits is standard in analytical reports; limits vary between instruments and column conditions. Purity values reported as 99%+ typically indicate either very high synthetic yield or that impurities fall below the quantification limit and are not individually reported.In vitro · PMID 25410642In vitro · PMID 35646620

Complementary Techniques and Method Validation

HPLC confirms the relative abundance of compounds but does not directly measure chemical identity. Two different molecular structures might have identical retention times, appearing as a single peak. Mass spectrometry (MS) complements HPLC by measuring exact molecular mass; LC-MS couples the chromatographic separation with mass detection, allowing confirmation that each peak corresponds to the expected molecular formula. Tandem MS (LC-MS/MS) fragments the peptide, providing sequence confirmation. Amino acid analysis—acid hydrolysis followed by quantification of individual amino acid content—provides an independent check on total peptide concentration and amino acid composition.In vitro · PMID 38968868Review · PMID 36526726

Method validation documents the reliability of the HPLC procedure. Validation experiments include accuracy testing (analyzing peptide standards of known purity to confirm the method reports the true value), precision testing (analyzing the same sample repeatedly to measure variability), and linearity testing (confirming that the response is proportional to concentration across the expected range). Validated methods have defined acceptance criteria: acceptable accuracy ranges and precision limits. Regulatory submissions and peer-reviewed publications typically require evidence of method validation.In vitro · PMID 33443297Review · PMID 27645457

The studies at a glance

Key HPLC parameters and their roles in peptide characterization

StudyStudy typenWeeksResult
RP-HPLC separation on C18 column with acetonitrile gradientIn vitron/an/aTarget peptide and synthesis impurities separated by hydrophobicity; baseline resolution achieved over 15–30 minute run time
UV detection at 214 nm for peptide bond absorptionReviewn/an/aPeptide bonds absorb strongly at 214 nm; method is sensitive and nonselective across all amino acid sequences
Peak integration and area-percent purity calculationReviewn/an/aSoftware identifies peak boundaries; purity reported as target peak area divided by total area; typical range 85–99% for research peptides
LC-MS confirmation of peak identity and massIn vitron/an/aEach HPLC peak characterized by mass-to-charge ratio; confirms target mass and detects isobaric impurities
Amino acid analysis of peptide compositionReviewn/an/aTotal amino acid content quantified; composition verified against theoretical sequence
Method validation by accuracy and precision testingIn vitron/an/aRepeated analysis of known standards; acceptance criteria defined; method suitable for regulatory and publication use

Frequently asked questions

What does 'area percent' purity mean?

Area-percent purity is the fraction of the total HPLC peak area occupied by the target compound. If a chromatogram shows one large peak at 95% and smaller peaks totaling 5%, the target compound comprises 95% of the measured material. This method assumes that all detected compounds have similar absorption coefficients at 214 nm—true for peptides because all contain peptide bonds. Area-percent differs from mass-percent purity, which accounts for differences in extinction coefficients; the two values usually differ by less than 5% for peptide mixtures.In vitro · PMID 33443297Review · PMID 35460196

Why is 214 nm the standard detection wavelength?

Peptide bonds (carbon-nitrogen linkages between amino acids) have a strong absorption maximum at 214 nm, making this wavelength ideal for detecting all peptides regardless of sequence. The alternative, 280 nm, detects aromatic amino acids (tryptophan, tyrosine) but misses peptides lacking these residues. Most HPLC methods for peptide purity use 214 nm as the primary detection wavelength because of its broad applicability and high sensitivity.Review · PMID 27645457Review · PMID 20369231

What limitations does HPLC have?

HPLC measures chromatographic separation and UV absorption, not chemical identity. Two different peptides could have the same retention time and appear as one peak, reducing purity accuracy. Also, HPLC cannot detect compounds that do not absorb UV light at the detection wavelength—salts, residual water, and some solvents go undetected. For comprehensive characterization, HPLC should be combined with mass spectrometry to confirm molecular mass and distinguish co-eluting compounds that might overlap on the chromatogram.In vitro · PMID 38968868Review · PMID 36526726

How is HPLC method development performed?

Method development involves testing different columns, mobile-phase compositions, temperature, and gradient programs to optimize separation of the target peptide from impurities. Development typically requires 10–30 experimental runs. Once a separation is achieved, the method is tested for reproducibility (repeated analyses show consistent retention times and peak areas) and then validated by testing standard peptides of known purity. Optimized methods are documented with defined parameters so they can be transferred to other laboratories or used across multiple samples.In vitro · PMID 33443297In vitro · PMID 24966037

What is the difference between HPLC and LC-MS?

HPLC couples liquid chromatography with UV detection; LC-MS couples it with mass spectrometry detection. HPLC is faster and less expensive, measuring purity by peak area. LC-MS provides additional confirmation of molecular identity and mass, allowing detection of co-eluting compounds (compounds with identical retention times but different masses). For research peptides, HPLC purity alone is often sufficient; LC-MS adds a second layer of confirmation and is useful when precise identity verification is required.In vitro · PMID 38968868In vitro · PMID 25410642

Cited literature

  1. Comprehensive UHPLC- and CE-based methods for engineered Cas9 characterization.Talanta · 2023PMID 35988299 ↗
  2. Solid-Phase Thiol-Ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist.Angewandte Chemie (International ed. in English) · 2018PMID 29978532 ↗
  3. A combination of multiple LC-MS approaches for the comprehensive characterization of cysteine-linked ADCs.Journal of pharmaceutical and biomedical analysis · 2024PMID 38968868 ↗
  4. Enfuvirtide biosynthesis in thermostable chaperone-based fusion.Biotechnology reports (Amsterdam, Netherlands) · 2022PMID 35646620 ↗
  5. High-Performance Reversed-Phase Flash Chromatography Purification of Peptides and Chemically Modified Insulins.Chembiochem : a European journal of chemical biology · 2021PMID 33443297 ↗
  6. Gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor enfuvirtide. [corrected].Biotechnology letters · 2014PMID 24966037 ↗
  7. Reprint of "Mixed-mode chromatography in pharmaceutical and biopharmaceutical applications".Journal of pharmaceutical and biomedical analysis · 2016PMID 27645457 ↗
  8. Comprehensive multi-attribute method workflow for biotherapeutic characterization and current good manufacturing practices testing.Nature protocols · 2023PMID 36526726 ↗
  9. Comprehensive two-dimensional liquid chromatography of therapeutic monoclonal antibody digests.Analytical and bioanalytical chemistry · 2015PMID 25410642 ↗
  10. Recent progress in online, comprehensive two-dimensional high-performance liquid chromatography for non-proteomic applications.Analytical and bioanalytical chemistry · 2010PMID 20369231 ↗
  11. Synthetic pharmaceutical peptides characterization by chromatography principles and method development.Journal of separation science · 2022PMID 35460196 ↗

Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.